Company profile for Cardiff Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clini...
At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clinical trials.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
11055 Flintkote Avenue San Diego, CA 92121
Telephone
Telephone
+1 858-952-7570
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/24/3193341/0/en/Cardiff-Oncology-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
24 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3183076/0/en/Cardiff-Oncology-Reports-Third-Quarter-2025-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180809/0/en/Cardiff-Oncology-to-Participate-in-Two-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/02/3160689/0/en/Cardiff-Oncology-to-Participate-in-Two-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
02 Oct 2025

https://www.globenewswire.com/news-release/2025/08/28/3141107/0/en/Cardiff-Oncology-to-Participate-in-Three-Upcoming-Investor-Conferences.html

GLOBENEWSWIRE
28 Aug 2025

https://www.fiercebiotech.com/biotech/investors-whale-cardiff-sinking-stock-after-seeing-updated-colorectal-cancer-data

FIERCE BIOTECH
30 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty